Development of point-of-care nanobiosensors for breast cancers diagnosis

Nanobiosensors have played a key role as portable devices in the rapid breast cancer diagnosis and in clinical medicine like point-of-care devices. However, understanding biomarkers and nanomaterials is crucial for improving the performance of nanobiosensors for all stages of different diseases or treatment. Therefore, this study not only investigates the effect of biomarkers and nanomaterials such as metallic, carbon structures and quantum dot on the accuracy of nanobiosensors for early detection of breast cancer, but also exhibits how they are used in vivo and in vitro and their application in point-of-care devices for personalized cancer diagnosis. Afterwards, application of fluidics and microchips as point-of-care nanobiosensors in the early detection of biomarkers associated with breast cancer diagnosis was discussed. Furthermore, the integration of nanobiosensors in nanomotors platforms for the treatment of breast cancer was overviewed. Finally, the ongoing challenges and future trends on the detection limit of nanobiosensors, their application in point-of-care clinical diagnostics and the approaches implemented for their improvements by highlighting the successful reports on the revolution of personalized diagnostics were surveyed.